Cedara and ANEXA to Deliver Integrated Digital Solutions to End Users

TORONTO, Canada and PEABODY, Massachusetts: November 18, 2004 -- Cedara Software Corp. (NASDAQ:CDSW/TSX:CDE) and ANEXA Corporation, a subsidiary of Analogic Corporation (NASDAQ: ALOGE), today announced that they have entered into a cooperative agreement to enable customers of either company to obtain complete, fully integrated digital imaging solutions to meet their imaging and image management needs.

ANEXA is a provider of digital imaging solutions for Digital Radiography (DR), advanced software applications, and other key products for select end-user markets.

Cedara is a leading independent developer of medical software technologies for the global healthcare market.

Under the agreement, the direct sales organizations of ANEXA and Cedara will promote each other’s products and work jointly to offer end users in the North American market complete, integrated imaging solutions, including advanced digital imaging equipment, application software packages, and PACS (Picture Archiving and Communications Systems) products. Cedara recently acquired eMed Technologies Corporation, widely known as a provider of innovative PACS and teleradiology solutions that have been installed in over 2,000 hospitals and imaging centers.

Loris Sartor, Cedara’s Vice President of Sales, stated, “This agreement represents a great opportunity for Cedara to work with a dynamic, innovative player in the DR marketplace. With the strong heritage in medical imaging of ANEXA’s parent company, Analogic, ANEXA is uniquely able to meet the needs of the DR market and provide specialized, highly integrated and cost-effective solutions.”

The acquisition consoles of ANEXA’s imaging products feature Cedara software. This allows seamless integration of Cedara’s image management tools, including Cedara’s I-SoftView™ and I-Reach™ PACS solutions, and the Cedara OrthoWorks™ clinical workstation for orthopedic planning.

Dennis Runyan, ANEXA’s Vice President of Sales, said, “We are delighted to be working with Cedara to provide our customers with comprehensive software products and PACS solutions that integrate seamlessly with ANEXA systems. Cedara’s products, combined with our own powerful DR systems, enable ANEXA to offer its customers complete, enhanced solutions for their radiography needs.”

For more information about Cedara, visit the Cedara website at www.cedara.com or contact:

Loris Sartor
Cedara Software Corp.
(905) 672-2100 ext. 2285
Email: info@cedara.com

For investor-related inquiries, contact:
Brian Pedlar, Chief Financial Officer
(905) 672-2100 ext. 2015
Email: brian.pedlar@cedara.com

For more information about ANEXA, visit www.anexanow.com or contact:
Dennis Runyan
ANEXA Corporation
1-800-423-8086
Email: drunyan@anexanow.com

About Cedara Software

Cedara Software Corp. is a leading independent provider of medical imaging technologies. Cedara software is deployed in hospitals and clinics worldwide and is licensed by many of the world’s leading medical device and healthcare information technology companies. Approximately 28,000 medical imaging systems and 6,400 Picture Archiving and Communications System (PACS) workstations have been licensed to date. Cedara recently acquired eMed Technologies Corporation, widely known as a provider of innovative PACS and teleradiology solutions which have been installed in over 2,000 hospitals and imaging centers. Cedara is quite unique in that it has technologies and expertise that span all the major digital imaging modalities including computed tomography (CT), magnetic resonance imaging (MRI), digital X-ray, mammography, ultrasound, echo-cardiology, angiography, nuclear medicine, positron emission tomography (PET) and fluoroscopy. Furthermore, the Company's medical imaging offerings are used in all aspects of clinical workflow including the capture of a patient’s digital image; the archiving, communication and manipulation of digital images; sophisticated clinical applications to analyze digital images; and even the use of imaging in minimally-invasive surgery.

About ANEXA

ANEXA Corporation is committed to opening new frontiers in digital imaging. Drawing on the extensive technology, experience, and resources of its people and partners, ANEXA offers a growing family of high-performance, Next-Generation Digital Imaging Solutions to meet the clinical challenges of today and tomorrow. ANEXA is a wholly owned subsidiary of Analogic Corporation, a leading designer and manufacturer of advanced health and security systems and subsystems sold primarily to Original Equipment Manufacturers (OEMs).

This press release contains the Company’s or management’s intentions, hopes, beliefs, expectations or predictions. These are considered “forward-looking statements” within the meaning of the Private Securities Litigation Act of 1995. Forward-looking statements (statements that are not historical facts) in this presentation are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that all forward-looking statements, including statements about product development, market and industry trends, strategic initiatives, regulatory approvals, sales, profits, expenses, price trends, research and development expenses and trends, and capital expenditures involve risk and uncertainties. Actual results may differ materially from those indicated by such statements as a result of various factors, including those discussed in the Company’s periodic reports filed with the SEC under the heading “Business Environment and Risk Factors.” In addition, the forward-looking statements included in this press release represent the Company’s views as of November 18, 2004. The Company anticipates that subsequent events and developments will cause the Company’s views to change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to November 18, 2004.